Filters

Human immunodeficiency virus type 2 subtype A Protein Vpx (vpx)

Human immunodeficiency virus type 2 subtype A Protein Vpx (vpx) size: 100ug 1398

Price 1398
Size 100ug
Long nameRecombinant Human immunodeficiency virus type 2 subtype A Protein Vpx (vpx)
Alternative names Protein Vpx, Viral protein X, X ORF protein, Protein Vpx
Gene namevpx
Other gene namesvpx
General description All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, Protein Vpx(vpx) is a recombinant protein expressed in Baculovirus
Product categoryRecombinant Proteins
Expression systemBaculovirus
Available also expressed in: Baculovirus , Mammalian Cell, Yeast , E Coli
PurityGreater than 90% (determined by SDS-PAGE)
FormLyophilized protein
Storage Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius
Applications IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetimmunodeficiency virus 2 subtype A Protein Vpx (vpx)
Short nameimmunodeficiency virus type 2 subtype A Protein Vpx (vpx)
Species Humans, Human
Alternative name sapiens immunodeficiency virus classification 2 subtype A Protein Vpx (vpx), H

Similar products

Subscribe to our Newsletter